Immune-Related Adverse Events After Combination Checkpoint Blockade: A Short Communication on Steroid-Sparing Practice. Translational Medicine & Therapeutics Journal, [S. l.], v. 3, n. 2, p. 110–119, 2024. DOI: 10.5281/zenodo.22649312. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/102. Acesso em: 5 nov. 2026.